H.R. 7188 · 118th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

Stage
Passed a chamber
Sponsor
John Moolenaar
Introduced
2024-02-01
Latest action
2024-12-17 · Received in the Senate.

Action history

  1. 2024-12-17Received in the Senate.
  2. 2024-12-16Motion to reconsider laid on the table Agreed to without objection.
  3. 2024-12-16On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  4. 2024-12-16DEBATE - The House proceeded with forty minutes of debate on H.R. 7188.
  5. 2024-12-16Considered under suspension of the rules.
  6. 2024-12-16Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
  7. 2024-11-22Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-766.
  8. 2024-11-22Placed on the Union Calendar, Calendar No. 632.
  9. 2024-09-18Committee Consideration and Mark-up Session Held
  10. 2024-09-18Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 0.
  11. 2024-05-16Subcommittee Consideration and Mark-up Session Held
  12. 2024-05-16Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 27 - 0.
  13. 2024-02-02Referred to the Subcommittee on Health.
  14. 2024-02-01Introduced in House
  15. 2024-02-01Referred to the House Committee on Energy and Commerce.